Literature DB >> 23255758

Assessing the relation between bone marrow signal intensity and apparent diffusion coefficient in diffusion-weighted MRI.

Anwar R Padhani1, Katherine van Ree, David J Collins, Shirley D'Sa, Andreas Makris.   

Abstract

OBJECTIVE: The purposes of this study were to observe the relation between signal intensity (SI) on MR images with a high b value and the apparent diffusion coefficient (ADC) of bone marrow on body diffusion-weighted MR images, to determine cutoff values that enable separation of malignant and normal bone marrow, and to identify the upper ADC values of untreated multiple myeloma lesions and bone metastatic lesions of breast cancer.
MATERIALS AND METHODS: Retrospective evaluations of 16 patients without bone disease, 21 patients with untreated metastases of breast cancer, and 12 patients with myeloma undergoing body diffusion-weighted MRI were performed (b values, 50 s/mm(2) and 800 or 900 s/mm(2)). Normal yellow and red bone marrow regions were compared with metastatic breast and myeloma bone marrow lesions (one to five regions of interest per patient). SI values were normalized to kidney, muscle, and spinal cord SI. Signal-to-noise ratio and ADC for each lesion were recorded. Nonparametric, receiver operating characteristic, and nonlinear regression analyses were performed.
RESULTS: Yellow bone marrow and red bone marrow ADC values were lower than the tumor values (p < 0.001; area under the curve, 0.94; cutoff, 774 μm(2)/s). Tissue-normalized SI and the signal-to-noise ratio of normal bone marrow were also lower than those in tumor regions (p < 0.001; area under the curve, 0.86-0.88). Second-order polynomial curve fitting between SI and ADC was observed (muscle normalized SI, R(2) = 0.4). The 95th percentile and maximum values for mean tumor ADC distribution were 1209 μm(2)/s and 1433 μm(2)/s.
CONCLUSION: Both tissue-normalized SI and ADC measurements allow differentiation between normal bone marrow and tumors of myeloma and breast cancer. The presence of a nonlinear relation between bone marrow SI and ADC values enables definition of an upper limit of ADC value for untreated myeloma lesions and metastatic lesions of breast cancer.

Entities:  

Mesh:

Year:  2013        PMID: 23255758     DOI: 10.2214/AJR.11.8185

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  45 in total

1.  Proton density fat fraction (PDFF) MRI for differentiation of benign and malignant vertebral lesions.

Authors:  Frederic Carsten Schmeel; Julian Alexander Luetkens; Peter Johannes Wagenhäuser; Michael Meier-Schroers; Daniel Lloyd Kuetting; Andreas Feißt; Jürgen Gieseke; Leonard Christopher Schmeel; Frank Träber; Hans Heinz Schild; Guido Matthias Kukuk
Journal:  Eur Radiol       Date:  2018-01-08       Impact factor: 5.315

2.  Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging of focal vertebral bone marrow lesions: initial experience of the differentiation of nodular hyperplastic hematopoietic bone marrow from malignant lesions.

Authors:  Sunghoon Park; Kyu-Sung Kwack; Nam-Su Chung; Jinwoo Hwang; Hyun Young Lee; Jae Ho Kim
Journal:  Skeletal Radiol       Date:  2017-03-06       Impact factor: 2.199

Review 3.  Imaging of distant metastases of prostate cancer.

Authors:  Filippo Pesapane; Marcin Czarniecki; Matteo Basilio Suter; Baris Turkbey; Geert Villeirs
Journal:  Med Oncol       Date:  2018-09-14       Impact factor: 3.064

4.  Repeatability and reproducibility of ADC measurements: a prospective multicenter whole-body-MRI study.

Authors:  Nicolas F Michoux; Jakub W Ceranka; Jef Vandemeulebroucke; Frank Peeters; Pierre Lu; Julie Absil; Perrine Triqueneaux; Yan Liu; Laurence Collette; Inneke Willekens; Carola Brussaard; Olivier Debeir; Stephan Hahn; Hubert Raeymaekers; Johan de Mey; Thierry Metens; Frédéric E Lecouvet
Journal:  Eur Radiol       Date:  2021-01-06       Impact factor: 5.315

Review 5.  Pediatric skeletal diffusion-weighted magnetic resonance imaging, part 2: current and emerging applications.

Authors:  Apeksha Chaturvedi
Journal:  Pediatr Radiol       Date:  2021-05-21

Review 6.  Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.

Authors:  Julie C Dutoit; Koenraad L Verstraete
Journal:  Skeletal Radiol       Date:  2017-03-13       Impact factor: 2.199

7.  Correlations between intravoxel incoherent motion diffusion-weighted MR imaging parameters and 18F-FDG PET/CT metabolic parameters in patients with vertebral bone metastases: initial experience.

Authors:  Sunghoon Park; Joon-Kee Yoon; Nam-Su Chung; Sang Hyun Kim; Jinwoo Hwang; Hyun Young Lee; Kyu-Sung Kwack
Journal:  Br J Radiol       Date:  2018-03-20       Impact factor: 3.039

8.  Role of diffusion-weighted imaging for detecting bone marrow infiltration in skull in children with acute lymphoblastic leukemia.

Authors:  Weiguo Cao; Changhong Liang; Yungan Gen; Chen Wang; Cailei Zhao; Longwei Sun
Journal:  Diagn Interv Radiol       Date:  2016 Nov-Dec       Impact factor: 2.630

Review 9.  Functional and molecular MRI of the bone marrow in multiple myeloma.

Authors:  Vassilis Koutoulidis; Nickolas Papanikolaou; Lia A Moulopoulos
Journal:  Br J Radiol       Date:  2018-02-13       Impact factor: 3.039

10.  Pyogenic and non-pyogenic spinal infections: emphasis on diffusion-weighted imaging for the detection of abscesses and pus collections.

Authors:  T Moritani; J Kim; A A Capizzano; P Kirby; J Kademian; Y Sato
Journal:  Br J Radiol       Date:  2014-07-07       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.